In comparison to the RECIST 1.1 criteria, use of the mpMRI-based NacBI-RADS system for evaluating response to neoadjuvant chemotherapy (NAC) for breast cancer offered an 8 percent higher sensitivity and over 26 percent higher specificity.
In a new podcast episode, Thomas Hope, MD, shares his insights on glioma imaging and the potential impact of the recently FDA-approved PET agent floretyrosine (18F-FET),
The a2z-Omni-Triage software reportedly facilitates adjunctive triage for a number of findings including pneumothorax, coccygeal fracture, bowel perforation and moderate or severe hydronephrosis.
In a recent interview, Phillip Koo, MD, shared his thoughts on the impact of AI in radiology and nuclear medicine, the emergence and potential with theranostics, and how patient empowerment has changed radiology reporting.
In a recent interview at the HLTH USA conference, Maria Ansari, MD, FACC, shared her perspective on the ongoing evolution of AI in health care and how it can facilitate the increasing emphasis on value-based care.